Procedure for Reviewing Pharmaceutical Inspections in the Eurasian Economic Union (Review)

Abstract

Introduction. The article discusses significant changes in the procedure for pharmaceutical inspection of drug manufacturers for compliance with the requirements of the rules of good manufacturing practice (GMP) of the Eurasian Economic Union (EAEU), related to restrictions due to the COVID-19 pandemic.Text. The article presents the main international guidelines describing the remote conduct of pharmaceutical inspections, which is the basis for further updating the relevant procedures in the law of the EAEU. An overview of the foreign practice of pharmaceutical inspection during the pandemic is given. In addition, the changes in the Russian regulatory approaches to control and supervision in the Russian legislation are presented.Conclusion. These data give an idea that, with considering the above, there is a need for further convergence of the requirements, the practice of conducting pharmaceutical inspections for compliance with the requirements of GMP Rules in order to harmonize the norms between Russian regulatory documents, the norms of the EAEU law and international standards. This requires the development of a dialogue with the participation of stakeholders.

Changes in renal function and morphological variations of kidney diseases in rheumatoid arthritis patients

“…[ 31 ] studied the peculiarities of the functional state of kidneys at RA. It was found that GFR in such patients decreased by 0.83 mL/min per year (95% CI −1.08 to −0.57) [ 32 , 33 ]. The study of Hickson et al.…”

Effect of newly detected hyperglycemia on the course of coronary heart disease

“…This monocyteendothelial interaction as one of the principal triggering mechanisms of atherogenesis is directly related to free radical oxidation of lipids and oxidative stress. By penetrating the vascular intima, monocytes accumulate oxidized lipids and become foamy cells that secrete some biologically active substances that are critical atherogenesis processes [28,29]. These are, in particular, such proinflammatory mediators as Eselectin, endothelial cell adhesion molecules-1, intercellular adhesion molecules-1, and others.…”